More than 1,000 eye care professionals worldwide have been using the AdaptDx® and AdaptDx Pro® to test for impaired dark adaptation, the earliest biomarker of age-related macular degeneration. Our customers tell the story of how they’re fighting against preventable blindness by identifying AMD at its earliest stages and closely monitoring its progression.
My patients recognize our practice as an AMD Center of Excellence with a commitment to preventing blindness through early diagnosis and management. MacuLogix has given our doctors the tool to be leaders in early AMD diagnosis.
Dark adaptation testing has allowed me to provide care earlier for many AMD patients. Science tells that I am helping these patients years before they would have developed, clinically evident disease. Patients appreciate this more proactive approach and are very accepting of it.
The AdaptDx Pro is a tool, that not only to gives you hope for better patient outcomes, which is the most important thing, but also helps you to grow your practice. There’s a huge opportunity because AMD is more prevalent than glaucoma, diabetes, and diabetic retinopathy combined.
The current standard is for us to wait around until we see macular degeneration progressing in someone’s eye. We now know we can identify it earlier, up to 3 years earlier before it ever shows up in their eye. I truly believe dark adaptation testing should be the standard of care.
I think it’s excellent that my doctor has AdaptDx because it can detect AMD at a very early stage. There’s a history of AMD in my family so I was very motivated to take the test.
The primary goal of every optometrist is to preserve the vision of our patients. Detecting, monitoring, and treating AMD are imperative to our mission. We can detect earlier than ever before and manage AMD by doing all we can to prevent progression to advanced stages and complications such as CNV.
The customer service education training and support that I receive from MacuLogix is second to none of any of the other companies in our profession.
I think it’s very important to see an eye doctor that has the latest technology because it gives you access to knowledge and the ability to find or diagnose issues with your eyes.
The AdaptDx Pro with Theia is a huge opportunity to differentiate yourself, become more medical, and have a more successful practice as well.
When I look at the future of managing macular degeneration, I see the AdaptDx as the essential tool in AMD management just as now I see the OCT as the essential tool in managing glaucoma in its earliest stages. By finding a disease early, and intervening appropriately we have the best chance of altering the course.